Lung cancer trial development at AstraZeneca has hit a setback. The company discontinued its Phase III eVOLVE-Lung02 study of volrustomig with chemotherapy in metastatic non-small cell lung cancer
Lupin has received a key FDA approval that strengthens its position in sleep disorder drugs. The approval covers its generic Pitolisant Tablets for the US market. The latest regulatory clearance allows Lupin to market Pitolisant Tablets in 4.45 mg...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
Telangana has brought its Food Safety Department and Drugs Control Administration under one administrative structure called the Telangana Standards Authority for Food and Essential Drugs
FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
.png "Sun Pharma Gets Major Relief in Lipitor Antitrust Litigation")
Sun Pharma has secured major relief in its long-running Antitrust litigation in the U.S. The company said a U.S. appeals court upheld a lower court ruling in its favor. The case relates to generic Lipitor and a patent settlement involving Ranbaxy...
The latest pharma updates spotlight key developments in drug safety, regulatory compliance, clinical practice, disease preparedness and global ambitions
Chandipura Virus cases have surged in Gujarat, with the death toll reaching 27. The state has reported 41 confirmed infections so far. The outbreak has raised concern due to the virus's rapid progression. Chandipura virus cases have mainly been...
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Manufacturing quality at Aurobindo Pharma's Eugia business faces renewed scrutiny after the US Food and Drug Administration issued a warning letter to its Unit-I facility in Telangana
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")